Skip to main content
Top
Published in: BMC Gastroenterology 1/2011

Open Access 01-12-2011 | Research article

An increased risk of urinary tract infection precedes development of primary biliary cirrhosis

Authors: Fumi K Varyani, Joe West, Timothy R Card

Published in: BMC Gastroenterology | Issue 1/2011

Login to get access

Abstract

Background

Primary Biliary Cirrhosis is known to be associated with Urinary Tract Infections (UTIs), but whether these precede or follow the liver disease is unclear. We have therefore attempted to determine whether UTIs are more common in people with Primary Biliary Cirrhosis (PBC) prior to their diagnosis.

Methods

We conducted a case control study in the General Practice Research Database. All cases of PBC first recorded at least one year after entry to the dataset were selected along with up to 10 controls matched for age, sex. A second unmatched control group who had Chronic Liver Diseases but not PBC were chosen. The main exposures studied were the occurrence of Urinary tract infections and pyelonephritis at least one or at least five years before diagnosis. We also performed an analysis restricted to those younger than 55 at diagnosis, as we hypothesized the relationship to be stronger in the younger age group.

Results

PBC is associated with UTI prior to diagnosis, OR 1.50 (CI 1.26-1.78), which was similar 5 years prior to diagnosis and after adjusting for smoking. The strongest relationships were observed in pyelonephritis exposures five years before diagnosis in cases under 55 years: adjusted odds ratios were 2.60 (1.02-6.63) in comparison with matched general population controls and adjusted odds ratios were OR 2.45 (1.02-5.59) in the comparison with chronic liver disease controls.

Conclusions

We found that the association between urosepsis and PBC is specific to this disease and precedes the diagnosis of PBC in a manner not previously observed in human data. This is consistent with a causal relationship.
Literature
1.
go back to reference van de Meeberg PC, Wolfhagen FH, van Erpecum KJ, van Berge Henegouwen GP: Cholestatic liver diseases: new strategies for prevention and treatment of hepatobiliary and cholestatic diseases. Neth J Med. 1995, 47 (1): 30-35. 10.1016/0300-2977(94)00115-P.CrossRefPubMed van de Meeberg PC, Wolfhagen FH, van Erpecum KJ, van Berge Henegouwen GP: Cholestatic liver diseases: new strategies for prevention and treatment of hepatobiliary and cholestatic diseases. Neth J Med. 1995, 47 (1): 30-35. 10.1016/0300-2977(94)00115-P.CrossRefPubMed
2.
go back to reference Hirschfield GM, Liu X, Xu C, Lu Y, Xie G, Lu Y, Gu X, Walker EJ, Jing K, Juran BD, et al: Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants. N Engl J Med. 2009, 360 (24): 2544-2555. 10.1056/NEJMoa0810440.CrossRefPubMedPubMedCentral Hirschfield GM, Liu X, Xu C, Lu Y, Xie G, Lu Y, Gu X, Walker EJ, Jing K, Juran BD, et al: Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants. N Engl J Med. 2009, 360 (24): 2544-2555. 10.1056/NEJMoa0810440.CrossRefPubMedPubMedCentral
4.
go back to reference Ala A, Stanca CM, Bu-Ghanim M, Ahmado I, Branch AD, Schiano TD, Odin JA, Bach N: Increased prevalence of primary biliary cirrhosis near Superfund toxic waste sites. Hepatology. 2006, 43 (3): 525-531. 10.1002/hep.21076.CrossRefPubMed Ala A, Stanca CM, Bu-Ghanim M, Ahmado I, Branch AD, Schiano TD, Odin JA, Bach N: Increased prevalence of primary biliary cirrhosis near Superfund toxic waste sites. Hepatology. 2006, 43 (3): 525-531. 10.1002/hep.21076.CrossRefPubMed
5.
go back to reference McNally RJ, Ducker S, James OF: Are transient environmental agents involved in the cause of primary biliary cirrhosis? Evidence from space-time clustering analysis. Hepatology. 2009, 50 (4): 1169-1174. 10.1002/hep.23139.CrossRefPubMed McNally RJ, Ducker S, James OF: Are transient environmental agents involved in the cause of primary biliary cirrhosis? Evidence from space-time clustering analysis. Hepatology. 2009, 50 (4): 1169-1174. 10.1002/hep.23139.CrossRefPubMed
6.
go back to reference Bogdanos DP, Vergani D: Bacteria and primary biliary cirrhosis. Clin Rev Allergy Immunol. 2009, 36 (1): 30-39. 10.1007/s12016-008-8087-9.CrossRefPubMed Bogdanos DP, Vergani D: Bacteria and primary biliary cirrhosis. Clin Rev Allergy Immunol. 2009, 36 (1): 30-39. 10.1007/s12016-008-8087-9.CrossRefPubMed
7.
go back to reference Berg CP, Kannan TR, Klein R, Gregor M, Baseman JB, Wesselborg S, Lauber K, Stein GM: Mycoplasma antigens as a possible trigger for the induction of antimitochondrial antibodies in primary biliary cirrhosis. Liver Int. 2009, 29 (6): 797-809. 10.1111/j.1478-3231.2008.01942.x.CrossRefPubMed Berg CP, Kannan TR, Klein R, Gregor M, Baseman JB, Wesselborg S, Lauber K, Stein GM: Mycoplasma antigens as a possible trigger for the induction of antimitochondrial antibodies in primary biliary cirrhosis. Liver Int. 2009, 29 (6): 797-809. 10.1111/j.1478-3231.2008.01942.x.CrossRefPubMed
8.
go back to reference Selmi C, Balkwill DL, Invernizzi P, Ansari AA, Coppel RL, Podda M, Leung PS, Kenny TP, Van De Water J, Nantz MH, et al: Patients with primary biliary cirrhosis react against a ubiquitous xenobiotic-metabolizing bacterium. Hepatology. 2003, 38 (5): 1250-1257. 10.1053/jhep.2003.50446.CrossRefPubMed Selmi C, Balkwill DL, Invernizzi P, Ansari AA, Coppel RL, Podda M, Leung PS, Kenny TP, Van De Water J, Nantz MH, et al: Patients with primary biliary cirrhosis react against a ubiquitous xenobiotic-metabolizing bacterium. Hepatology. 2003, 38 (5): 1250-1257. 10.1053/jhep.2003.50446.CrossRefPubMed
9.
go back to reference Smyk D, Rigopoulou EI, Baum H, Burroughs AK, Vergani D, Bogdanos DP: Autoimmunity and Environment: Am I at risk?. Clin Rev Allergy Immunol. 2011 Smyk D, Rigopoulou EI, Baum H, Burroughs AK, Vergani D, Bogdanos DP: Autoimmunity and Environment: Am I at risk?. Clin Rev Allergy Immunol. 2011
10.
go back to reference Bogdanos DP, Baum H, Butler P, Rigopoulou EI, Davies ET, Ma Y, Burroughs AK, Vergani D: Association between the primary biliary cirrhosis specific anti-sp100 antibodies and recurrent urinary tract infection. Dig Liver Dis. 2003, 35 (11): 801-805. 10.1016/S1590-8658(03)00466-3.CrossRefPubMed Bogdanos DP, Baum H, Butler P, Rigopoulou EI, Davies ET, Ma Y, Burroughs AK, Vergani D: Association between the primary biliary cirrhosis specific anti-sp100 antibodies and recurrent urinary tract infection. Dig Liver Dis. 2003, 35 (11): 801-805. 10.1016/S1590-8658(03)00466-3.CrossRefPubMed
11.
go back to reference Bogdanos DP, Baum H, Vergani D, Burroughs AK: The role of E. coli infection in the pathogenesis of primary biliary cirrhosis. Dis Markers. 2010, 29 (6): 301-311.CrossRefPubMed Bogdanos DP, Baum H, Vergani D, Burroughs AK: The role of E. coli infection in the pathogenesis of primary biliary cirrhosis. Dis Markers. 2010, 29 (6): 301-311.CrossRefPubMed
12.
go back to reference Winstanley TG, Limb DI, Eggington R, Hancock F: A 10 year survey of the antimicrobial susceptibility of urinary tract isolates in the UK: the Microbe Base project. J Antimicrob Chemother. 1997, 40 (4): 591-594. 10.1093/jac/40.4.591.CrossRefPubMed Winstanley TG, Limb DI, Eggington R, Hancock F: A 10 year survey of the antimicrobial susceptibility of urinary tract isolates in the UK: the Microbe Base project. J Antimicrob Chemother. 1997, 40 (4): 591-594. 10.1093/jac/40.4.591.CrossRefPubMed
13.
go back to reference Bogdanos DP, Baum H, Grasso A, Okamoto M, Butler P, Ma Y, Rigopoulou E, Montalto P, Davies ET, Burroughs AK, et al: Microbial mimics are major targets of crossreactivity with human pyruvate dehydrogenase in primary biliary cirrhosis. Journal of hepatology. 2004, 40 (1): 31-39. 10.1016/S0168-8278(03)00501-4.CrossRefPubMed Bogdanos DP, Baum H, Grasso A, Okamoto M, Butler P, Ma Y, Rigopoulou E, Montalto P, Davies ET, Burroughs AK, et al: Microbial mimics are major targets of crossreactivity with human pyruvate dehydrogenase in primary biliary cirrhosis. Journal of hepatology. 2004, 40 (1): 31-39. 10.1016/S0168-8278(03)00501-4.CrossRefPubMed
14.
go back to reference Burroughs AK, Rosenstein IJ, Epstein O, Hamilton-Miller JM, Brumfitt W, Sherlock S: Bacteriuria and primary biliary cirrhosis. Gut. 1984, 25 (2): 133-137. 10.1136/gut.25.2.133.CrossRefPubMedPubMedCentral Burroughs AK, Rosenstein IJ, Epstein O, Hamilton-Miller JM, Brumfitt W, Sherlock S: Bacteriuria and primary biliary cirrhosis. Gut. 1984, 25 (2): 133-137. 10.1136/gut.25.2.133.CrossRefPubMedPubMedCentral
15.
go back to reference Gershwin ME, Selmi C, Worman HJ, Gold EB, Watnik M, Utts J, Lindor KD, Kaplan MM, Vierling JM: Risk factors and comorbidities in primary biliary cirrhosis: a controlled interview-based study of 1032 patients. Hepatology. 2005, 42 (5): 1194-1202. 10.1002/hep.20907.CrossRefPubMedPubMedCentral Gershwin ME, Selmi C, Worman HJ, Gold EB, Watnik M, Utts J, Lindor KD, Kaplan MM, Vierling JM: Risk factors and comorbidities in primary biliary cirrhosis: a controlled interview-based study of 1032 patients. Hepatology. 2005, 42 (5): 1194-1202. 10.1002/hep.20907.CrossRefPubMedPubMedCentral
16.
go back to reference Howel D, Fischbacher CM, Bhopal RS, Gray J, Metcalf JV, James OF: An exploratory population-based case-control study of primary biliary cirrhosis. Hepatology. 2000, 31 (5): 1055-1060. 10.1053/he.2000.7050.CrossRefPubMed Howel D, Fischbacher CM, Bhopal RS, Gray J, Metcalf JV, James OF: An exploratory population-based case-control study of primary biliary cirrhosis. Hepatology. 2000, 31 (5): 1055-1060. 10.1053/he.2000.7050.CrossRefPubMed
17.
go back to reference Parikh-Patel A, Gold EB, Worman H, Krivy KE, Gershwin ME: Risk factors for primary biliary cirrhosis in a cohort of patients from the united states. Hepatology. 2001, 33 (1): 16-21. 10.1053/jhep.2001.21165.CrossRefPubMed Parikh-Patel A, Gold EB, Worman H, Krivy KE, Gershwin ME: Risk factors for primary biliary cirrhosis in a cohort of patients from the united states. Hepatology. 2001, 33 (1): 16-21. 10.1053/jhep.2001.21165.CrossRefPubMed
18.
go back to reference Prince MI, Ducker SJ, James OF: Case-control studies of risk factors for primary biliary cirrhosis in two United Kingdom populations. Gut. 59 (4): 508-512. Prince MI, Ducker SJ, James OF: Case-control studies of risk factors for primary biliary cirrhosis in two United Kingdom populations. Gut. 59 (4): 508-512.
19.
go back to reference Walley T, Mantgani A: The UK General Practice Research Database. Lancet. 1997, 350 (9084): 1097-1099. 10.1016/S0140-6736(97)04248-7.CrossRefPubMed Walley T, Mantgani A: The UK General Practice Research Database. Lancet. 1997, 350 (9084): 1097-1099. 10.1016/S0140-6736(97)04248-7.CrossRefPubMed
20.
go back to reference Jick SS, Kaye JA, Vasilakis-Scaramozza C, Garcia Rodriguez LA, Ruigomez A, Meier CR, Schlienger RG, Black C, Jick H: Validity of the general practice research database. Pharmacotherapy. 2003, 23 (5): 686-689. 10.1592/phco.23.5.686.32205.CrossRefPubMed Jick SS, Kaye JA, Vasilakis-Scaramozza C, Garcia Rodriguez LA, Ruigomez A, Meier CR, Schlienger RG, Black C, Jick H: Validity of the general practice research database. Pharmacotherapy. 2003, 23 (5): 686-689. 10.1592/phco.23.5.686.32205.CrossRefPubMed
21.
go back to reference Metcalf JV, Bhopal RS, Gray J, Howel D, James OF: Incidence and prevalence of primary biliary cirrhosis in the city of Newcastle upon Tyne, England. Int J Epidemiol. 1997, 26 (4): 830-836. 10.1093/ije/26.4.830.CrossRefPubMed Metcalf JV, Bhopal RS, Gray J, Howel D, James OF: Incidence and prevalence of primary biliary cirrhosis in the city of Newcastle upon Tyne, England. Int J Epidemiol. 1997, 26 (4): 830-836. 10.1093/ije/26.4.830.CrossRefPubMed
22.
go back to reference Hoepelman AI, Meiland R, Geerlings SE: Pathogenesis and management of bacterial urinary tract infections in adult patients with diabetes mellitus. Int J Antimicrob Agents. 2003, 22 (Suppl 2): 35-43.CrossRefPubMed Hoepelman AI, Meiland R, Geerlings SE: Pathogenesis and management of bacterial urinary tract infections in adult patients with diabetes mellitus. Int J Antimicrob Agents. 2003, 22 (Suppl 2): 35-43.CrossRefPubMed
23.
go back to reference Prince M, Chetwynd A, Newman W, Metcalf JV, James OF: Survival and symptom progression in a geographically based cohort of patients with primary biliary cirrhosis: follow-up for up to 28 years. Gastroenterology. 2002, 123 (4): 1044-1051. 10.1053/gast.2002.36027.CrossRefPubMed Prince M, Chetwynd A, Newman W, Metcalf JV, James OF: Survival and symptom progression in a geographically based cohort of patients with primary biliary cirrhosis: follow-up for up to 28 years. Gastroenterology. 2002, 123 (4): 1044-1051. 10.1053/gast.2002.36027.CrossRefPubMed
24.
go back to reference James OF, Bhopal R, Howel D, Gray J, Burt AD, Metcalf JV: Primary biliary cirrhosis once rare, now common in the United Kingdom?. Hepatology. 1999, 30 (2): 390-394. 10.1002/hep.510300213.CrossRefPubMed James OF, Bhopal R, Howel D, Gray J, Burt AD, Metcalf JV: Primary biliary cirrhosis once rare, now common in the United Kingdom?. Hepatology. 1999, 30 (2): 390-394. 10.1002/hep.510300213.CrossRefPubMed
25.
go back to reference Jackson H, Solaymani-Dodaran M, Card TR, Aithal GP, Logan R, West J: Influence of ursodeoxycholic acid on the mortality and malignancy associated with primary biliary cirrhosis: a population-based cohort study. Hepatology. 2007, 46 (4): 1131-1137. 10.1002/hep.21795.CrossRefPubMed Jackson H, Solaymani-Dodaran M, Card TR, Aithal GP, Logan R, West J: Influence of ursodeoxycholic acid on the mortality and malignancy associated with primary biliary cirrhosis: a population-based cohort study. Hepatology. 2007, 46 (4): 1131-1137. 10.1002/hep.21795.CrossRefPubMed
26.
go back to reference West J, Card TR, Solaymani-Dodaran M, Logan RFA, Aithal G: Incidence of Primary Biliary Cirrhosis: a UK population-based study. British Association of the Study of the Liver Annual Meeting. 2004, Cambridge West J, Card TR, Solaymani-Dodaran M, Logan RFA, Aithal G: Incidence of Primary Biliary Cirrhosis: a UK population-based study. British Association of the Study of the Liver Annual Meeting. 2004, Cambridge
27.
go back to reference Ewies AA, Alfhaily F: Topical vaginal estrogen therapy in managing postmenopausal urinary symptoms: a reality or a gimmick?. Climacteric. 2010, 13 (5): 405-418. 10.3109/13697137.2010.500748.CrossRefPubMed Ewies AA, Alfhaily F: Topical vaginal estrogen therapy in managing postmenopausal urinary symptoms: a reality or a gimmick?. Climacteric. 2010, 13 (5): 405-418. 10.3109/13697137.2010.500748.CrossRefPubMed
28.
go back to reference Amano K, Leung PS, Rieger R, Quan C, Wang X, Marik J, Suen YF, Kurth MJ, Nantz MH, Ansari AA, et al: Chemical xenobiotics and mitochondrial autoantigens in primary biliary cirrhosis: identification of antibodies against a common environmental, cosmetic, and food additive, 2-octynoic acid. J Immunol. 2005, 174 (9): 5874-5883.CrossRefPubMed Amano K, Leung PS, Rieger R, Quan C, Wang X, Marik J, Suen YF, Kurth MJ, Nantz MH, Ansari AA, et al: Chemical xenobiotics and mitochondrial autoantigens in primary biliary cirrhosis: identification of antibodies against a common environmental, cosmetic, and food additive, 2-octynoic acid. J Immunol. 2005, 174 (9): 5874-5883.CrossRefPubMed
29.
go back to reference Stemerowicz R, Hopf U, Moller B, Wittenbrink C, Rodloff A, Reinhardt R, Freudenberg M, Galanos C: Are antimitochondrial antibodies in primary biliary cirrhosis induced by R(rough)-mutants of enterobacteriaceae?. Lancet. 1988, 2 (8621): 1166-1170.CrossRefPubMed Stemerowicz R, Hopf U, Moller B, Wittenbrink C, Rodloff A, Reinhardt R, Freudenberg M, Galanos C: Are antimitochondrial antibodies in primary biliary cirrhosis induced by R(rough)-mutants of enterobacteriaceae?. Lancet. 1988, 2 (8621): 1166-1170.CrossRefPubMed
30.
go back to reference Palermo JJ: W1846 Recurrent Urinary Tract Infection in Mice Results in Immune-Mediated Cholangiopathy Similar to Human Primary Biliary Cirrhosis. Gastroenterology. 2008, 134 (4, Supplement 1): A-837.CrossRef Palermo JJ: W1846 Recurrent Urinary Tract Infection in Mice Results in Immune-Mediated Cholangiopathy Similar to Human Primary Biliary Cirrhosis. Gastroenterology. 2008, 134 (4, Supplement 1): A-837.CrossRef
31.
go back to reference Butler P, Valle F, Hamilton-Miller JM, Brumfitt W, Baum H, Burroughs AK: M2 mitochondrial antibodies and urinary rough mutant bacteria in patients with primary biliary cirrhosis and in patients with recurrent bacteriuria. J Hepatol. 1993, 17 (3): 408-414. 10.1016/S0168-8278(05)80225-9.CrossRefPubMed Butler P, Valle F, Hamilton-Miller JM, Brumfitt W, Baum H, Burroughs AK: M2 mitochondrial antibodies and urinary rough mutant bacteria in patients with primary biliary cirrhosis and in patients with recurrent bacteriuria. J Hepatol. 1993, 17 (3): 408-414. 10.1016/S0168-8278(05)80225-9.CrossRefPubMed
Metadata
Title
An increased risk of urinary tract infection precedes development of primary biliary cirrhosis
Authors
Fumi K Varyani
Joe West
Timothy R Card
Publication date
01-12-2011
Publisher
BioMed Central
Published in
BMC Gastroenterology / Issue 1/2011
Electronic ISSN: 1471-230X
DOI
https://doi.org/10.1186/1471-230X-11-95

Other articles of this Issue 1/2011

BMC Gastroenterology 1/2011 Go to the issue